Addus Homecare (ADUS) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Addus Homecare Corp  (NASDAQ: ADUS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Addus Homecare's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Addus Homecare in the second quarter 2026?
Addus Homecare Corp achieved a return on average equity (ROE) of 9.57 % in its second quarter 2026, this is above ADUS's average return on equity of 9.11%.
Addus Homecare Corp shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $1,100 million

ROE has advanced compared to 9.34% in the first quarter 2026, due to net income growth.

Within the Healthcare Facilities industry 20 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 1508 to 1511.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Equity Change 12.36 % 12.13 % 11.83 % 10.8 % -
Y / Y Net Income Change 25.19 % 18.09 % 52.52 % 13.32 % 21.98 %
Net Income (TTM) in Millions 105 100 96 86 83
Return On Equity (TTM) 9.57 % 9.34 % 9.24 % 8.49 % 8.43 %
ADUS's Total Ranking # 1511 # 1508 # 1131 # 1371 # 1220
Equity (TTM) in Millions 1,148 1,116 1,085 1,050 1,022
Seq. Equity Change 2.87 % 2.84 % 3.36 % 2.75 % 2.66 %
Seq. Net Income Change 10.12 % -15.82 % 30.35 % 3.61 % 3.88 %

Back to ADUS Management Effectiveness >> ADUS's 5 Years Annual ROE >> Compare ADUS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 21
Sector # 147
Overall # 1511

Return On Equity Statistics
High Average Low
21.25 %
9.11 %
5.34 %
(Mar 31 2013)   (Sep 30 2016)





ADUS Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 1,085 970 707 634 574
Y / Y Equity Change 11.83 % 37.33 % 11.55 % 10.31 % 10.73 %
Net Income in Millions 96 74 63 46 45
Y / Y Net Income Change 30.32 % 17.73 % 35.83 % 1.99 % 36.2 %
Return On Equity 8.84 % 7.58 % 8.85 % 7.26 % 7.86 %

Back to ADUS Management Effectiveness >> ADUS's 5 Years Annual ROE >> Compare ADUS ROE to its Competitors




Annual Roe Comment
In 2025 ROE improved to 8.84 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ADUS's' Return on Equity at Yahoo Finance
ADUS's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ADUS's Competitors
Subscribers only: Roe for Addus Homecare's Suppliers
Subscribers only: Return On Equity for ADUS's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %
Resmed Inc   24.21 %
Healthcare Services Group Inc   24.12 %
Electromed Inc   23.65 %
Iradimed Corporation  23.45 %
Vertex Pharmaceuticals Inc  23.31 %
Lantheus Holdings Inc   23.27 %
Msa Safety Inc  23.15 %
Prestige Consumer Healthcare Inc   21.77 %
Jazz Pharmaceuticals Plc  21.37 %
Neurocrine Biosciences Inc   21.13 %
Universal Health Services Inc   20.89 %
Puma Biotechnology Inc   20.85 %
Entera Bio Ltd   20.82 %
United Therapeutics Corporation  20.18 %
Ligand Pharmaceuticals Incorporated  20.06 %
Harmony Biosciences Holdings inc   20.06 %
Pediatrix Medical Group Inc   19.89 %
Theravance Biopharma inc   19.40 %
Krystal Biotech Inc   19.34 %
Ani Pharmaceuticals Inc  19.33 %
Brightspring Health Services Inc   18.93 %
Sbc Medical Group Holdings Incorporated  18.69 %
West Pharmaceutical Services Inc   18.51 %
Intuitive Surgical Inc   17.82 %
Standard Biotools Inc   17.64 %
Inspire Medical Systems inc   17.62 %
Medinotec Inc   17.47 %

Date modified: 2026-09-26T07:09:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.